Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
80 hedge funds and large institutions have $125M invested in Infinity Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 30 reducing their positions, and 21 closing their positions.
139% more capital invested
Capital invested by funds: $52.1M → $125M (+$72.6M)
46% more call options, than puts
Call options by funds: $536K | Put options by funds: $368K
15% less funds holding
Funds holding: 94 → 80 (-14)
23% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 30
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.19M |
| 2 |
DM
Deerfield Management
New York
|
+$4.84M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.51M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.26M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.62M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.6M |
| 3 |
Millennium Management
New York
|
-$1.35M |
| 4 |
Renaissance Technologies
New York
|
-$642K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$603K |
INFI Hedge Fund Activity: Q1 2017 in Review
80 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2017, worth a combined $125M — up 139% from $52.1M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of INFI and 12 opened new positions — a net loss of 9 holders — while 30 trimmed existing stakes and 23 added.
The largest buyer was BlackRock, adding an estimated $7.19M. The largest seller was Numeric Investors, cutting an estimated $1.62M.
- 80 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2017, down from 94 in Q4 2016.
- Funds reported $125M of Infinity Pharmaceuticals, Inc. stock for Q1 2017, up 139% quarter-over-quarter.
- 12 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2017 and 21 closed out, a net change of -9 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $7.19M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q1 2017 was Numeric Investors, an estimated $1.62M sold.
Based on aggregated 13F filings for Q1 2017.